Last update:
Oncology & Cancer news
Oncology & Cancer
Study reveals insights into DDX41 protein's role in blood cancer pathogenesis
A study led by Professors Hongtae Kim and JaYil Lee from the Department of Biological Sciences, in collaboration with researchers from the Catholic University of Korea, sheds light on the pivotal role of mutated DDX41 protein ...
2 hours ago
0
32
Oncology & Cancer
Liver cancer: Molecular signaling pathway of tumor development decoded
As a malignant disease of the liver cells, hepatocellular carcinoma (HCC) is one of the main causes of cancer-related deaths. While the treatment options for this aggressive type of cancer remain limited, the incidence is ...
3 hours ago
0
10
A sustainable diagnosis tool for multiple cancers
An accurate, affordable, environmentally and user-friendly diagnostic tool for multiple cancers—including pancreatic, gastric, and colorectal cancers—is reported in a paper in Nature Sustainability. The tool can diagnose ...
5 hours ago
0
7
FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer
The U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, which is marketed under the brand name Anktiva, to be used in combination with the immunotherapy Bacillus Calmette-Guerin (BCG) ...
2 hours ago
0
0
Arthritis linked to blood cancer mutations
A team of Adelaide and U.S. researchers has discovered a link between a less common form of rheumatoid arthritis and gene mutations found in blood cancer.
2 hours ago
0
0
Recent findings show cancer takes tough toll on family finances
About six out of 10 working-age adults hit with a cancer diagnosis say it put real pressure on their financial survival, a new report finds.
3 hours ago
0
0
Alecensa approved as first and only anaplastic lymphoma kinase inhibitor for non-small cell lung cancer
The U.S. Food and Drug Administration has approved Genentech's Alecensa (alectinib) as adjuvant treatment following tumor resection in patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC).
6 hours ago
0
0
Improving cancer immunotherapy by prolonging T-cell survival
In the past decade, immunotherapy has emerged as the fourth pillar of cancer treatment, joining surgery, radiotherapy and chemotherapy. It is an approved treatment for 15 cancers, including melanoma and some types of lymphomas ...
23 hours ago
0
43
Research team reports on blood-based multi-omics guided detection of a precancerous pancreatic tumor
A new case report published in OMICS: A Journal of Integrative Biology describes how longitudinal multi-omics monitoring (LMOM) helped to detect a precancerous pancreatic tumor and led to a successful surgical intervention.
Apr 22, 2024
0
1
Hitchhiking of synthetic antigen stimulates antibody production against cancer cells
Researchers at the Indian Institute of Science (IISc) have designed a synthetic compound (antigen) that can latch on to a protein in blood and hitchhike a ride to the lymph node, where it can boost the production of antibodies ...
Apr 22, 2024
0
15
Researchers find obese people and tall, centrally obese people are more likely to get colorectal cancer
A large international team of medical researchers has found that people with two types of body shape are more likely to develop colorectal cancer than people with other body types. In their study, published in the journal ...
Genetically engineering a treatment for incurable brain tumors
Purdue University researchers are developing and validating a patent-pending treatment for incurable glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional ...
Apr 22, 2024
0
29
Expert reviews the current state of retinoblastoma research
Retinoblastoma is a rare pediatric cancer, with approximately 250–300 new cases per year in the United States and 8,000 worldwide. The cancer grows within the retina, a thin layer of cells at the back of the eye, and is ...
Apr 22, 2024
0
0
Writing to wellness: New therapy helps cancer patients face biggest fears
Imagine your greatest fear. Now, write it down and tell it in first-person, as if it's happening right now. Vividly describe what it looks, sounds, smells, tastes and feels like. Don't hold back.
Apr 22, 2024
0
8
Neighborhood disadvantage tied to shorter breast cancer-specific survival
Neighborhood disadvantage is associated with shorter breast cancer-specific survival, according to a study published online April 18 in JAMA Network Open.
Apr 22, 2024
0
0
Review explores cutaneous manifestations of myelodysplastic syndrome
Cutaneous manifestations of myelodysplastic syndrome (MDS) are described in a perspective piece published in the April issue of Skin Health and Disease.
Apr 22, 2024
0
0
How does aspirin help prevent colorectal cancer development and progression?
Long-term daily use of aspirin can help to prevent the development and progression of colorectal cancer, but the mechanisms involved have been unclear. New research has revealed that aspirin may exert these protective effects ...
Apr 22, 2024
0
3
Researchers develop a new way to safely boost immune cells to fight cancer
Last year alone, more than 600,000 people in the United States died from cancer, according to the American Cancer Society. The relentless pursuit of understanding this complex disease has shaped medical progress in developing ...
Apr 19, 2024
0
113
Using AI to trace the origins of metastatic cancer cells
A large team of cancer researchers affiliated with several institutions in China, working with a pair of colleagues in the U.S., has found that artificial intelligence applications can be used to trace the origins of metastatic ...
Study of cancer-induced liver inflammation finds a promising therapeutic target
Liver inflammation, a common side-effect of cancers elsewhere in the body, has long been associated with worse cancer outcomes and more recently associated with poor response to immunotherapy. Now, a team led by researchers ...
Apr 19, 2024
0
34
